The global neurotrophic keratitis treatment market is expected to achieve a valuation of USD 5 billion in 2023 and is projected to grow significantly at a compound annual growth rate (CAGR) of 7.17% until 2033, reaching approximately USD 10 billion. This growth can be attributed to the rising incidence of neurotrophic keratitis, a debilitating condition …